Publication Cover
Redox Report
Communications in Free Radical Research
Volume 14, 2009 - Issue 3
3,701
Views
38
CrossRef citations to date
0
Altmetric
Research articles

Oxidative stress and total antioxidant capacity in human plasma

, , , &
Pages 125-131 | Published online: 19 Jul 2013

References

  • Sies H. Oxidative Stress: Oxidants and Antioxidants. New York: Academic Press, 1991.
  • Fiers W, Beyaert R, Declercq W, Vandenabeele P. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 1999; 18: 7719–7730.
  • Bridgen ML. Clinical utility of the erythrocyte sedimentation rate. Am Fam Phys 1999; 60: 1443–1450.
  • Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 2004; 142: 231-255.
  • Tarpey MM, Wink DA, Grisham MB. Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am J Physiol 2004; 286: R431–R444.
  • Jackson MJ. An overview of methods for assessment of free radical activity in biology. Proc Nutr Soc 1999; 58: 1001–1006.
  • Kopani M, Celec P, Danisovic L, Michalka P, Biro C. Oxidative stress and electron spin resonance. Clin Chim Acta 2006; 364: 61–66.
  • Tatzber F, Griebenow S, Wonisch W, Winkler R. Dual method for the determination of peroxidase activity and total peroxides-iodide leads to a significant increase of peroxidase activity in human sera. Anal Biochem 2003; 316: 147–153.
  • Alberti A, Bolognini L, Macciantelli D, Caratelli M. The radical cation of N,N-diethyl-para-phenylenediamine: a possible indicator of oxidative stress in biological samples. Res Chem Intermediat 2000; 26: 253–267.
  • Panagia A. Uso di un agente cromogeno per la determinazione di radicali liberi in un campione biologico. Italian Patent ITMI20021019, November, 142003.
  • Gay CA, Gebicki JM. Measurement of protein and lipid hydroperoxides in biological systems by the ferric—xylenol orange method. Anal Biochem 2003; 315: 29–35.
  • Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38: 1103–1111.
  • Miller NJ, Rice Evans C., Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Gin Sci 1993; 84: 407–412.
  • Janaszewska A, Bartosz G. Assay of total antioxidant capacity: comparison of four methods as applied to human blood plasma. Scand J C1M Lab Invest 2002; 62: 231–236.
  • Harma MI, Harma M, Erel O. d-ROMs test detects ceruloplasmin, not oxidative stress. Chest 2006; 130: 1276–1277.
  • Harma MI, Harma M, Erel O. Are d-ROMs and FRAP tests suitable assays for detecting the oxidative status? Eur J Obstet Gynecol Reprod Biol 2006; 127: 271–275.
  • Harma MI, Harma M, Erel O. The FORT test: a novel oxidative stress marker or a well-known measure of ceruloplasmin oxidase activity? Atherosclerosis 2006; 187: 441–442.
  • Sunderman Jr FW, Nomoto S. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin Chem 1970; 16: 903–910.
  • Abramson JL, Jones DP. The Fort test: reply to Dr Harma and colleagues. Atherosclerosis 2006; 187: 443–444.
  • Carratelli M. Reagent for the determination of free radicals. International Patent WO 96/09540, March, 28 1996.
  • Harma M, Harma M., Erel O. Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 2003; 133: 563–566.
  • Eadie WT, Drijard D, James FE, Roos M, Sadoulet B. Statistical Methods in Experimental Physics. Amsterdam: 1971,269–271.
  • Alberg AJ. The influence of cigarette smoking in concentrations of antioxidant micronutrients. Toxicology 2002; 180: 121–137.
  • El-Zayadi AR. Heavy smoking and liver. World J Gastroenterol 2006; 14: 6098–6101.
  • Zowczak M, Iskra M, Paszkowski J, Manczak M, Torlinski L, Wysocka E. Oxidase activity of ceruloplasmin and concentrations of copper and zinc in serum of cancer patients. J Trace Elem Med Biol 2001; 15: 193–196.
  • Lindblom A, Liljegren A. Tumour markers in malignancies. BMJ 2000; 320: 424–427.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.